3. Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
Prepaid manufacturing and research expenses |
|
$ |
3,214 |
|
|
$ |
1,908 |
|
Prepaid insurance |
|
|
40 |
|
|
|
262 |
|
Prepaid professional fees |
|
|
185 |
|
|
|
223 |
|
GST receivable |
|
|
813 |
|
|
|
817 |
|
Other |
|
|
391 |
|
|
|
422 |
|
Total prepaid expenses and other current assets |
|
$ |
4,643 |
|
|
$ |
3,632 |
|
Property and Equipment, Net Property and equipment, net as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
Equipment |
|
$ |
223 |
|
|
$ |
223 |
|
Furniture and fixtures |
|
|
18 |
|
|
|
18 |
|
Property and equipment, at cost |
|
|
241 |
|
|
|
241 |
|
Less accumulated depreciation |
|
|
(151 |
) |
|
|
(112 |
) |
Total property and equipment, net |
|
$ |
90 |
|
|
$ |
129 |
|
Other Assets Other assets as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
Clinical trial deposits |
|
$ |
2,404 |
|
|
$ |
2,036 |
|
Other |
|
|
146 |
|
|
|
25 |
|
Total other assets |
|
$ |
2,550 |
|
|
$ |
2,061 |
|
Accrued Liabilities Accrued liabilities as of June 30, 2026 and December 31, 2025 consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
June 30, 2026 |
|
|
December 31, 2025 |
|
Accrued legal and professional fees |
|
$ |
408 |
|
|
$ |
163 |
|
Accrued compensation |
|
|
1,412 |
|
|
|
2,250 |
|
Accrued manufacturing and research expenses |
|
|
2,999 |
|
|
|
7,374 |
|
Accrued issuance costs |
|
|
40 |
|
|
|
40 |
|
Deferred R&D credit |
|
|
1,337 |
|
|
|
927 |
|
Accrued other expenses |
|
|
83 |
|
|
|
8 |
|
Total accrued liabilities |
|
$ |
6,279 |
|
|
$ |
10,762 |
|
|